NDAORAL-21TABLET
Approved
Apr 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TRI-NORINYL 21-DAY (ethinyl estradiol; norethindrone) by Dr. Reddy's Laboratories. Approved for pregnancy. First approved in 1984.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRI-NORINYL 21-DAY is a triphasic oral contraceptive combining ethinyl estradiol and norethindrone in varying doses across a 21-day cycle. It prevents pregnancy through hormonal suppression of ovulation and alteration of cervical mucus and endometrial environment. This product represents a mature, established hormonal contraceptive option in the women's health market.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30%), signaling preparation for generic erosion and potential team rightsizing on the brand side.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Career Relevance
Working on TRI-NORINYL offers limited growth potential given LOE approaching status and zero current linked job openings; career value lies in defending mature market share and managing generic transition. Professionals should expect team contraction and may consider lateral moves to growth-stage contraceptive innovations or adjacent therapeutic areas within Dr. Reddy's portfolio.
Brand Manager
Worked on TRI-NORINYL 21-DAY at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.